<font color="blue">Epidemiology_1</font> <font color="blue">of_1</font> <font color="blue">stroke_2</font> <font color="blue">._2</font> Importance of <font color="blue">preventive_1</font> <font color="blue">pharmacological_1</font> <font color="blue">strategies_1</font> <font color="blue">in_1</font> <font color="blue">elderly_3</font> <font color="blue">patients_3</font> <font color="blue">and_1</font> <font color="blue">associated_1</font> <font color="blue">costs_1</font> <font color="blue">._1</font> 
<br>
<br> <font color="blue">Stroke_1</font> <font color="blue">is_1</font> <font color="blue">a_1</font> <font color="blue">major_1</font> <font color="blue">cause_1</font> <font color="blue">of_1</font> <font color="blue">death_1</font> <font color="blue">and_1</font> <font color="blue">disability_1</font> <font color="blue">in_1</font> <font color="blue">developed_1</font> <font color="blue">countries_1</font> <font color="blue">._1</font> The incidence of stroke increases exponentially with age , yet , traditionally , many medical practitioners have been reluctant to treat <font color="blue">hypertension_4</font> <font color="blue">in_4</font> <font color="blue">older_4</font> <font color="blue">patients_4</font> <font color="blue">._4</font> <font color="blue">Since_2</font> <font color="blue">1991_2</font> <font color="blue">,_2</font> <font color="blue">the_2</font> <font color="blue">results_2</font> <font color="blue">of_2</font> <font color="blue">3_2</font> <font color="blue">major_2</font> <font color="blue">trials_2</font> <font color="blue">--_2</font> <font color="blue">the_2</font> <font color="blue">British_3</font> <font color="blue">Medical_3</font> <font color="blue">Research_3</font> <font color="blue">Council_3</font> <font color="blue">(_3</font> <font color="blue">MRC_3</font> <font color="blue">)_3</font> <font color="blue">trial_3</font> <font color="blue">of_3</font> <font color="blue">treatment_4</font> <font color="blue">in_4</font> <font color="blue">older_4</font> <font color="blue">adults_4</font> <font color="blue">,_4</font> <font color="blue">the_3</font> <font color="blue">Swedish_3</font> <font color="blue">Trial_3</font> <font color="blue">in_3</font> <font color="blue">Old_3</font> <font color="blue">Patients_3</font> <font color="blue">with_3</font> <font color="blue">Hypertension_3</font> <font color="blue">(_3</font> <font color="blue">STOP_3</font> <font color="blue">-_3</font> <font color="blue">Hypertension_3</font> <font color="blue">)_3</font> <font color="blue">and_3</font> <font color="blue">the_3</font> <font color="blue">Systolic_3</font> <font color="blue">Hypertension_3</font> <font color="blue">in_3</font> <font color="blue">the_3</font> <font color="blue">Elderly_3</font> <font color="blue">Program_3</font> <font color="blue">(_3</font> <font color="blue">SHEP)--have_3</font> <font color="blue">conclusively_3</font> <font color="blue">established_3</font> <font color="blue">the_3</font> <font color="blue">benefits_3</font> <font color="blue">of_3</font> <font color="blue">treating_4</font> <font color="blue">older_5</font> <font color="blue">patients_5</font> <font color="blue">(_5</font> <font color="blue">>_5</font> <font color="blue">60_5</font> <font color="blue">years_5</font> <font color="blue">)_5</font> <font color="blue">with_4</font> <font color="blue">both_4</font> <font color="blue">diastolic_4</font> <font color="blue">and_4</font> <font color="blue">isolated_4</font> <font color="blue">systolic_4</font> <font color="blue">hypertension_4</font> <font color="blue">._4</font> International guidelines for the management of hypertension -- including the Fifth Report of the Joint National Committee , the 1993 report of the World Health Organization and the International Society of Hypertension and the second report of the British Hypertension Society Working Party -- have all been modified to reflect the emerging evidence concerning the benefits of treating older patients . Cost - effectiveness data are similarly in accord with giving high priority to <font color="blue">the_1</font> <font color="blue">treatment_2</font> <font color="blue">of_2</font> <font color="blue">older_3</font> <font color="blue">individuals_3</font> <font color="blue">with_3</font> <font color="blue">hypertension_3</font> <font color="blue">._3</font>